How COVID-19 Spurs Schizophrenia Risk?

Listen to this News

Highlights:

• COVID-19 can increase the risk of developing mental health issues like schizophrenia following infection
• The risk of post-COVID risk of schizophrenia is higher among young individuals
• Vigilant monitoring of the mental well-being of COVID-19 survivors is crucial for the early detection and intervention of psychiatric disorders

The ongoing evolution of COVID-19 and its various variants has resulted in a global crisis with widespread consequences, creating countless ripple effects that extend across multiple aspects, including mental health.

Even amidst the resurgence of COVID-19 cases, a recent study has established a connection between SARS-CoV-2 infections and an elevated likelihood of early-onset mental health issues such as schizophrenia (1^✔).

What is Schizophrenia?

Schizophrenia is a severe mental disorder marked by hallucinations, delusions, and cognitive disturbances. Previous studies have hinted at viruses, including the flu and now COVID-19, as potential triggers for schizophrenia.

‘A significant link between COVID-19 and an increased risk of developing schizophrenia spectrum disorder and psychotic disorders emphasizes the importance of mental health monitoring post-COVID infection. #covid19 #schizophrenia #mentalhealth #medindia’

The newly conducted study, yet to undergo peer review, observed a notable rise in the probability of being diagnosed with schizophrenia spectrum and psychotic disorders (SSPD) after experiencing moderate to severe illness due to SARS-CoV-2 infection. This was compared against a group who had non-COVID Acute Respiratory Distress Syndrome (ARDS) .

Here are some Top Facts on Schizophrenia

COVID's Impact on Mental Health Disorders

The study meticulously sifted through data from 19,344,698 patients to create comparable groups: ARDS, COVID-positive, and COVID-negative. They examined the risk rate of new-onset SSPD across three distinct timeframes: 0-21 days, 22-90 days, and beyond 90 days post-infection.

The findings consistently demonstrated that COVID-19-positive patients exhibited a notably heightened risk ratio across all intervals, surpassing both ARDS and COVID-negative patients. Intriguingly, the results highlighted a greater risk of SSPD among younger individuals after contracting COVID-19, a trend not observed in the ARDS and COVID-negative groups.

View Non AMP Site | Back to top ↑